Alexander, E. H., Rivera, F., Marriott, I.,Anguita, J., Bost, K. L. & Hudson, M. C. (2003) Staphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiology, 3(1), 5.
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. & Kudo, A. (2000) Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. JBiol Chem, 275(7), 4858-64.
Boyle, W. J., Simonet, W. S. & Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature, 423(6937), 337-342.
Church, D., Melnyk, E. & Unger, B. (2000) Quantitative Gram Stain Interpretation Criteria Used by Microbiology Laboratories inAlberta, Canada. Journal of Clinical Microbiology, 38(11), 4266-4268.
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P.A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R. & Denosumab Rheumatoid Arthritis Study, G. (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis:Atwelve- month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis & Rheumatism, 58(5), 1299-1309.
Funao, H., Ishii, K., Nagai, S., Sasaki,A., Hoshikawa, T.,Aizawa, M., Okada, Y., Chiba, K., Koyasu, S., Toyama, Y. & Matsumoto, M. (2012) Establishment of a Real-Time, Quantitative, and Reproducible Mouse Model of Staphylococcus Osteomyelitis Using Bioluminescence Imaging. Infection and Immunity, 80(2), 733-741.
Furuya, Y., Mori, K., Ninomiya, T., Tomimori, Y., Tanaka, S., Takahashi, N., Udagawa, N., Uchida, K. & Yasuda, H. (2011) Increased Bone Mass in Mice after Single Injection ofAnti-receptorActivator of Nuclear Factor-κB Ligand-neutralizingAntibody. Journal of Biological Chemistry, 286(42), 37023- 37031.
Garrido-Gómez, J., Arrabal-Polo, M. A., Girón-Prieto, M. S., Cabello-Salas, J., Torres-Barroso, J. & Parra-Ruiz, J. (2013) Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system ofAndalusia. JArthroplasty, 28(7), 1057-60.
H, Mirel. (1989) Metastatic disease in long bones.Aproposed scoring system for diagnosing impending pathologic fractures. . Clin Orthop Relat Res .
Hawkshead, J. J., Patel, N. B., Steele, R. W. & Heinrich, S. D. (2009) Comparative Severity of Pediatric OsteomyelitisAttributable to Methicillin-Resistant Versus Methicillin-Sensitive Staphylococcus aureus. Journal of Pediatric Orthopaedics, 29(1), 85-90.
Hodsman,A. B., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D.A., Harris, S. T., Kendler, D. L., McClung, M. R., Miller, P. D., Olszynski, W. P., Orwoll, E. & Yuen, C. K. (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev, 26(5), 688-703.
Ishimi, Y., Miyaura, C., Jin, C. H.,Akatsu, T.,Abe, E., Nakamura, Y., Yamaguchi,A., Yoshiki, S., Matsuda, T. & Hirano, T. (1990) IL-6 is produced by osteoblasts and induces bone resorption. The Journal of Immunology, 145(10), 3297.
Jorge, L. S., Chueire,A. G. & Baptista Rossit,A. R. (2010) Osteomyelitis: a current challenge. The Brazilian Journal of Infectious Diseases, 14(3), 310-315.
Klosterhalfen, B., Peters, K. M., Tons, C., Hauptmann, S., Klein, C. L. & Kirkpatrick, C. J. (1996) Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J Trauma, 40(3), 372-8.
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T. J. & Suda, T. (2000) Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction. Journal of Experimental Medicine, 191(2), 275-286.
Kokabu T, Takahata M, Ishiguro N, Iwasaki N. Long-term prognosis of hematogenous vertebral osteomyelitis: Mortality, quality of life, and pain.J Orthop Sci. 2017 Sep;22(5):822-827.
Kudo, O., Sabokbar,A., Pocock,A., Itonaga, I., Fujikawa, Y. &Athanasou, N. A. (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone, 32(1), 1-7.
Lacey, D. C., Simmons, P. J., Graves, S. E. & Hamilton, J.A. (2009) Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis and Cartilage, 17(6), 735-742.
Lau, Y. S., Wang, W., Sabokbar, A., Simpson, H., Nair, S., Henderson, B., Berendt,A. & Athanasou, N.A. (2006) Staphylococcus aureus capsular material promotes osteoclast formation. Injury, 37(2), S41-S48.
Lew, D. P. & Waldvogel, F.A. (1997) Osteomyelitis. New England Journal of Medicine, 336(14), 999- 1007.
Li, D., Gromov, K., Proulx, S. T., Xie, C., Li, J., Crane, D. P., Søballe, K., O’Keefe, R. J., Awad, H.A., Xing, L. & Schwarz, E. M. (2010) Effects of antiresorptive agents on osteomyelitis : Novel insights on osteonecrosis of the jaw (ONJ) pathogenesis. Annals of the New York Academy of Sciences, 1192(1), 84- 94.
Mackowiak, P.A., Jones, S. R. & Smith, J. W. (1978) Diagnostic Value of Sinus-tract Cultures in Chronic Osteomyelitis. Jama, 239(26), 2772.
Marriott, I. (2013)Apoptosis-associated uncoupling of bone formation and resorption in osteomyelitis. Front Cell Infect Microbiol, 3, 101.
Morita, M., Iwasaki, R., Sato, Y., Kobayashi, T., Watanabe, R., Oike, T., Nakamura, S., Keneko, Y., Miyamoto, K., Ishihara, K., Iwakura, Y., Ishii, K., Matsumoto, M., Nakamura, M., Kawana, H., Nakagawa, T. & Miyamoto, T. (2017) Elevation of pro-inflammatory cytokine levels following anti- resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Scientific Reports, 7(1), 46322.
O'Brien, W., Fissel, B. M., Maeda, Y., Yan, J., Ge, X., Gravallese, E. M., Aliprantis,A. O.& Charles, J. F. (2016) RANK-Independent Osteoclast Formation and Bone Erosion in InflammatoryArthritis. Arthritis & Rheumatology, 68(12), 2889-2900.
Perry, C. R. (1999) Bone Repair Techniques, Bone Graft, and Bone Graft Substitutes. Clinical Orthopaedics and Related Research®, 360.
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R. & Roodman, D. G. (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. Journal of Bone and Mineral Research, 4(1), 113-118.
Reichert, J. C., Saifzadeh, S., Wullschleger, M. E., Epari, D. R., Schütz, M.A., Duda, G. N., Schell, H., van Griensven, M., Redl, H. & Hutmacher, D. W. (2009) The challenge of establishing preclinical models for segmental bone defect research. Biomaterials, 30(12), 2149-63.
Roelofs,A. J., Thompson, K., Gordon, S. & Rogers, M. J. (2006) Molecular Mechanisms ofAction of Bisphosphonates: Current Status. Clinical Cancer Research, 12(20), 6222s.
Sims, N.A., Green, J. R., Glatt, M., Schlict, S., Martin, T. J., Gillespie, M. T. & Romas, E. (2004) Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum, 50(7), 2338-46.
Takahata, M.,Awad, H.A., O'Keefe, R. J., Bukata, S. V. & Schwarz, E. M. (2012) Endogenous tissue engineering: PTH therapy for skeletal repair. Cell Tissue Res, 347(3), 545-52.
Terashima,A., Okamoto, K., Nakashima, T.,Akira, S., Ikuta, K. & Takayanagi, H. (2016) Sepsis-Induced OsteoblastAblation Causes Immunodeficiency. Immunity, 44(6), 1434-1443.
Tice, A. D., Hoaglund, P.A. & Shoultz, D.A. (2003) Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. The American Journal of Medicine, 114(9), 723-728.
Wiessman, M. P., Liberty, I. F., Segev, R. W., Katz, T.,Abu Tailakh, M. & Novack, V. (2015) Clinical characteristics and survival of patients with diabetes mellitus following non-traumatic lower extremity amputation. Isr Med Assoc J, 17(3), 145-9.
Yeo,A. & Ramachandran, M. (2014) Acute haematogenous osteomyelitis in children. BMJ, 348(jan20 3), g66-g66.
Yoshii, T., Magara, S., Miyai, D., Nishimura, H., Kuroki, E., Furudoi, S., Komori, T. & Ohbayashi, C. (2002) Local levels of interleukin-1β,-4,-6, and tumor necrosis factor α in an experimental model of murine osteomyelitis due to Staphylococcus aureus. Cytokine, 19(2), 59-65.